Proteomic analysis of a PDEF ets transcription factor-interacting protein complex

Journal of Proteome Research

Volumn 8, Issue 3, 2009, Pages 1327-1337

  Cho, Je Yoel ^a,b   Lee, Minjung ^a,b   Ann, Jung Mo ^a,b   Park, Eun Sung ^a,b   Cho, Ji Hoon ^a,b   Lee, Seung Jin ^a,b   Kim, Byung Gyu ^a,b   Heo, Sun Hee ^a,b   Park, Hye Jeong ^a,b   Zerbini, Luiz F ^c   Hwang, Daehee ^a,b   Libermann, Towia A ^c  

^a Kyungpook National University   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Breast cancer; LC MS MS; Prostate derived ETS transcription factor

Indexed keywords

ADENOVIRUS VECTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROSTATE DERIVED ETS TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOSKELETON; DNA REPAIR; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PROCESSING; RNA SYNTHESIS; SIGNAL TRANSDUCTION; VIRAL GENE DELIVERY SYSTEM;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL NUCLEUS; CHROMATOGRAPHY, LIQUID; CYTOPLASM; FEMALE; HUMANS; IMMUNOPRECIPITATION; PROTEIN BINDING; PROTEOME; PROTO-ONCOGENE PROTEINS C-ETS; TANDEM MASS SPECTROMETRY;

EID: 65249159638     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr800683b     Document Type: Article

References (36)

1. Leprince, D.; Gegonne, A.; Coll, J.; de Taisne, C.; Schneeberger, A.; Lagrou, C.; Stehelin, D. A putative second cell-derived oncogene of the avian leukaemia retrovirus E26. Nature 1983, 306 (5941), 395-7.
2. Li, R.; Pei, H.; Watson, D. K. Regulation of Ets function by protein - protein interactions. Oncogene 2000, 19 (55), 6514-23.
3. Turner, D. P.; Watson, D. K. ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer. Expert Rev. Anticancer Ther. 2008, 8 (1), 33-42.
4. Han, B.; Mehra, R.; Dhanasekaran, S. M.; Yu, J.; Menon, A.; Lonigro, R. J.; Wang, X.; Gong, Y.; Wang, L.; Shankar, S.; Laxman, B.; Shah, R. B.; Varambally, S.; Palanisamy, N.; Tomlins, S. A.; Kumar-Sinha, C.; Chinnaiyan, A. M. A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5- ETV4 fusion protein in prostate cancer. Cancer Res. 2008, 68 (18), 7629-37.
5. Kumar-Sinha, C.; Tomlins, S. A.; Chinnaiyan, A. M. Recurrent gene fusions in prostate cancer. Nat. Rev. Cancer 2008, 8 (7), 497-511.
6. Morris, D. S.; Tomlins, S. A.; Montie, J. E.; Chinnaiyan, A. M. The discovery and application of gene fusions in prostate cancer. BJU Int. 2008, 102 (3), 276-82.
7. Wasylyk, B.; Hagman, J.; Gutierrez-Hartmann, A. Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway. Trends Biochem. Sci. 1998, 23 (6), 213-6.
8. Oettgen, P.; Finger, E.; Sun, Z.; Akbarali, Y.; Thamrongsak, U.; Boltax, J.; Grall, F.; Dube, A.; Weiss, A.; Brown, L.; Quinn, G.; Kas, K.; Endress, G.; Kunsch, C.; Libermann, T. A. >PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression. J. Biol. Chem. 2000, 275 (2), 1216-25.
9. Chen, H.; Bieberich, C. J. Structural and functional analysis of domains mediating interaction between NKX-3.1 and PDEF. J. Cell Biochem. 2005, 94 (1), 168-77.
10. Ghadersohi, A.; Sood, A. K. Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumors and is a candidate breast tumor marker and a breast tumor antigen. Clin. Cancer Res. 2001, 7 (9), 2731-8.
11. Gunawardane, R. N.; Sgroi, D. C.; Wrobel, C. N.; Koh, E.; Daley, G. Q.; Brugge, J. S. Novel role for PDEF in epithelial cell migration and invasion. Cancer Res. 2005, 65 (24), 11572-80.
12. Feldman, R. J.; Sementchenko, V. I.; Gayed, M.; Fraig, M. M.; Watson, D. K. Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression. Cancer Res. 2003, 63 (15), 4626-31.
13. Ghadersohi, A.; Pan, D.; Fayazi, Z.; Hicks, D. G.; Winston, J. S.; Li, F. Prostate-derived Ets transcription factor (PDEF) downregulates survivin expression and inhibits breast cancer cell growth in vitro and xenograft tumor formation in vivo. Breast Cancer Res. Treat. 2007, 102 (1), 19-30.
14. Kim, Y. J.; Kim, B. G.; Lee, S. J.; Lee, H. K.; Lee, S. H.; Ryoo, H. M.; Cho, J. Y. The suppressive effect of myeloid Elf-1-like factor (MEF) in osteogenic differentiation. J. Cell Physiol. 2007, 211 (1), 253-60.
15. Barabasi, A. L.; Oltvai, Z. N. Network biology: understanding the cell's functional organization. Nat. Rev. Genet. 2004, 5 (2), 101-13.
16. Watts, D. J.; Strogatz, S. H. Collective dynamics of 'small-world' networks. Nature 1998, 393 (6684), 440-2.
17. Gu, X.; Zerbini, L. F.; Otu, H. H.; Bhasin, M.; Yang, Q.; Joseph, M. G.; Grall, F.; Onatunde, T.; Correa, R. G.; Libermann, T. A. Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells. Cancer Res. 2007, 67 (9), 4219-26.
18. Amorim, B. R.; Okamura, H.; Yoshida, K.; Qiu, L.; Morimoto, H.; Haneji, T. The transcriptional factor Osterix directly interacts with RNA helicase A. Biochem. Biophys. Res. Commun. 2007, 355 (2), 347-51.
19. Landgraf, R. HER2 therapy. HER2 (ERBB2): functional diversity from structurally conserved building blocks. Breast Cancer Res. 2007, 9 (1), 202.
20. Barginear, M. F.; Bradley, T.; Shapira, I.; Budman, D. R. Implications of applied research for prognosis and therapy of breast cancer. Crit. Rev. Oncol. Hematol. 2008, 65 (3), 223-34.
21. Chariyalertsak, S.; Chariyalertsak, S.; Cheirsilpa, A.; Chindavijak, K. Prognostic importance of p53 and c-erbB-2 oncoproteins overexpression in patients with breast cancer. J. Med. Assoc. Thai 1998, 81 (9), 698-704.
22. Kato, T.; Kameoka, S.; Kimura, T.; Nishikawa, T.; Kobayashi, M. C-erbB-2 and PCNA as prognostic indicators of long-term survival in breast cancer. Anticancer Res. 2002, 22 (2B), 1097-103.
23. Koscielny, S.; Terrier, P.; Spielmann, M.; Delarue, J. C. Prognostic importance of low c-erbB2 expression in breast tumors. J. Natl. Cancer Inst. 1998, 90 (9), 712.
24. Carpenter, G. Nuclear localization and possible functions of receptor tyrosine kinases. Curr. Opin. Cell Biol. 2003, 15 (2), 143-8.
25. Burger, M. J.; Tebay, M. A.; Keith, P. A.; Samaratunga, H. M.; Clements, J.; Lavin, M. F.; Gardiner, R. A. Expression analysis of delta-catenin and prostate-specific membrane antigen: their potential as diagnostic markers for prostate cancer. Int. J. Cancer 2002, 100 (2), 228-37.
26. Bose, R.; Molina, H.; Patterson, A. S.; Bitok, J. K.; Periaswamy, B.; Bader, J. S.; Pandey, A.; Cole, P. A. Phosphoproteomic analysis of Her2/neu signaling and inhibition. Proc. Natl. Acad. Sci. U.S.A. 2006, 103 (26), 9773-8.
27. Kraus, M. H.; Popescu, N. C.; Amsbaugh, S. C.; King, C. R. Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J. 1987, 6 (3), 605-10.
28. Revillion, F.; Hornez, L.; Peyrat, J. P. Quantification of c-erbB-2 gene expression in breast cancer by competitive RT-PCR. Clin. Chem. 1997, 43 (11), 2114-20.
29. Tanaka, H.; Terada, Y.; Kobayashi, T.; Okado, T.; Inoshita, S.; Kuwahara, M.; Seth, A.; Sato, Y.; Sasaki, S. Expression and function of Ets-1 during experimental acute renal failure in rats. J. Am. Soc. Nephrol. 2004, 15 (12), 3083-92.
30. Wen, S. C.; Ku, D. H.; De Luca, A.; Claudio, P. P.; Giordano, A.; Calabretta, B. ets-2 regulates cdc2 kinase activity in mammalian cells: coordinated expression of cdc2 and cyclin A. Exp. Cell Res. 1995, 217 (1), 8-14.
31. Kasten, M.; Giordano, A. Cdk10, a Cdc2-related kinase, associates with the Ets2 transcription factor and modulates its transactivation activity. Oncogene 2001, 20 (15), 1832-8.
32. Bagella, L.; Giacinti, C.; Simone, C.; Giordano, A. Identification of murine cdk10: association with Ets2 transcription factor and effects on the cell cycle. J. Cell Biochem. 2006, 99 (3), 978-85.
33. Xiao, K.; McClatchy, D. B.; Shukla, A. K.; Zhao, Y.; Chen, M.; Shenoy, S. K.; Yates, J. R.; Lefkowitz, R. J. Functional specialization of {beta}-arrestin interactions revealed by proteomic analysis. Proc. Natl. Acad. Sci. U.S.A. 2007.
34. Thompson, H. G.; Harris, J. W.; Wold, B. J.; Lin, F.; Brody, J. P. p62 overexpression in breast tumors and regulation by prostate- derived Ets factor in breast cancer cells. Oncogene 2003, 22 (15), 2322-33.
35. Shin, J. P62 and the sequestosome, a novel mechanism for protein metabolism. Arch. Pharm. Res. 1998, 21 (6), 629-33.
36. Chen, H.; Nandi, A. K.; Li, X; Bieberich, C. J. NKX-3.1 interacts with prostate-derived Ets factor and regulates the activity of the PSA promoter. Cancer Res. 2002, 62 (2), 338-40.